SC 13D
XBRL
SC 13D
- Company
- Editas Medicine, Inc.
- Filed
- May 16, 2016
- Accession Number
- 0001193125-16-591961
A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →